An imaging biomarker to detect non-glucogenic shift in brain energy metabolism in Alzheimer’s disease一种用于检测阿尔茨海默病中大脑能量代谢非糖原性转变的影像生物标志物Journal of Translational MedicineIF7.52026-05-200OAAI
In vivo imaging of glutamate uncovers the neuroprotective effects of nicotinamide riboside on excitotoxicity in an Alzheimer’s mouse modelAlzheimer's Research & TherapyIF7.62026-01-300OAAI
Detection of sex-specific glutamate changes in subregions of hippocampus in an early-stage Alzheimer's disease mouse model using GluCEST MRIALZHEIMERS & DEMENTIAIF11.12024-09-110OA
Early-stage mapping of macromolecular content in APPNL-F mouse model of Alzheimer's disease using nuclear Overhauser effect MRIFRONTIERS IN AGING NEUROSCIENCEIF4.52023-10-094OAAI
In vivo assessment of β-hydroxybutyrate metabolism in mouse brain using deuterium (2H) MRSMAGNETIC RESONANCE IN MEDICINEIF32023-03-274PRE
Feasibility of transient nuclear Overhauser effect imaging in brain at 7 TMAGNETIC RESONANCE IN MEDICINEIF32022-11-134PRE
Identification of l-Tryptophan by down-field 1H MRS: A precursor for brain NAD+ and serotonin synthesesMAGNETIC RESONANCE IN MEDICINEIF32022-08-258OA
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive DisorderFRONTIERS IN PSYCHIATRYIF3.22021-04-27105OAAI
Brain energy metabolism in intracerebroventricularly administered streptozotocin mouse model of Alzheimer's disease: A 1H-[13C]-NMR studyJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMIF4.52021-03-0311OAAI